[1]
“Liposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues”, Braz. J. Pharm. Sci., vol. 53, no. 2, p. e16127-, Jan. 2017, doi: 10.1590/s2175-97902017000216127.